Severe factor VII deficiency caused by a novel point mutation (Arg353Pro) combined with a rare Cys22Arg mutation

Thromb Haemost 2007; 98(03): 687-688
DOI: 10.1160/TH07-02-0126

Letters to the Editor

Schattauer GmbH

Wang Zhidong

¹The Institute of Hematology and People’s Hospital, Peking University, Beijing, P. R. China

,

Huang Xiaojun

¹The Institute of Hematology and People’s Hospital, Peking University, Beijing, P. R. China

References
1 Mariani G, Herrmann FH, Dolce A. et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005; 93: 481-487.
2 Hewitt J, Ballard JN, Nelson TN. et al. Severe FVII deficiency caused by a new point mutation combined with a previously undetected gene deletion. Br J Haematol 2005; 128: 380-385.
3 McVey JH, Boswell E, Mumford AD. et al. Factor VII deficiency and the FVII mutation database. Hum Mutat 2001; 17: 3-17.
4 Green F, Kelleher C, Wilkes H. et al. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-546.
5 Hunault M, Arbini AA, Lopaciuk S. et al. The Arg353Gln polymorphism reduces the level of coagulation factor VII in vivo and in vitro studies. Arteriosclerosis Thromb Vasc Biol 1997; 17: 2825-2829.
6 Fromovich-Amit Y, Zivelin A, Rosenberg N. et al. Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients. J Thromb Haemost 2004; 2: 1774-1781.
7 Soriano-Garcia M, Padmanabhan K, de Vos AM. et al. The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 1992; 31: 2554-2566.